These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 30138606)
1. Dephosphorylated rather than hyperphosphorylated Tau triggers a pro-inflammatory profile in microglia through the p38 MAPK pathway. Perea JR; Ávila J; Bolós M Exp Neurol; 2018 Dec; 310():14-21. PubMed ID: 30138606 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. Li Y; Liu L; Barger SW; Griffin WS J Neurosci; 2003 Mar; 23(5):1605-11. PubMed ID: 12629164 [TBL] [Abstract][Full Text] [Related]
3. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology. Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048 [TBL] [Abstract][Full Text] [Related]
4. Regulation of tau pathology by the microglial fractalkine receptor. Bhaskar K; Konerth M; Kokiko-Cochran ON; Cardona A; Ransohoff RM; Lamb BT Neuron; 2010 Oct; 68(1):19-31. PubMed ID: 20920788 [TBL] [Abstract][Full Text] [Related]
5. The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production. Zheng LT; Hwang J; Ock J; Lee MG; Lee WH; Suk K J Neurochem; 2008 Dec; 107(5):1225-35. PubMed ID: 18786164 [TBL] [Abstract][Full Text] [Related]
6. p38 activation occurs mainly in microglia in the P301S Tauopathy mouse model. Perea JR; García E; Vallés-Saiz L; Cuadros R; Hernández F; Bolós M; Avila J Sci Rep; 2022 Feb; 12(1):2130. PubMed ID: 35136118 [TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide mediates HAPI microglia inflammatory response and subsequent neuron apoptosis through p38/JNK MAPK/STAT3 pathway. Mao J; Yang J; Zhang Y; Li T; Wang C; Xu L; Hu Q; Wang X; Jiang S; Nie X; Chen G Toxicol Appl Pharmacol; 2016 Jul; 303():79-89. PubMed ID: 27174766 [TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory treatment with the p38 mitogen-activated protein kinase inhibitor SB239063 is neuroprotective, decreases the number of activated microglia and facilitates neurogenesis in oxygen-glucose-deprived hippocampal slice cultures. Strassburger M; Braun H; Reymann KG Eur J Pharmacol; 2008 Sep; 592(1-3):55-61. PubMed ID: 18638472 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Quintanilla RA; Orellana DI; González-Billault C; Maccioni RB Exp Cell Res; 2004 Apr; 295(1):245-57. PubMed ID: 15051507 [TBL] [Abstract][Full Text] [Related]
10. Secreted beta-amyloid precursor protein activates microglia via JNK and p38-MAPK. Bodles AM; Barger SW Neurobiol Aging; 2005 Jan; 26(1):9-16. PubMed ID: 15585341 [TBL] [Abstract][Full Text] [Related]
11. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells. Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY; Chan EWL J Ethnopharmacol; 2018 May; 217():187-194. PubMed ID: 29462698 [TBL] [Abstract][Full Text] [Related]
12. Effect of c-Jun N-terminal kinase (JNK)/p38 mitogen-activated protein kinase (p38 MAPK) in morphine-induced tau protein hyperphosphorylation. Cao M; Liu F; Ji F; Liang J; Liu L; Wu Q; Wang T Behav Brain Res; 2013 Jan; 237():249-55. PubMed ID: 23026374 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I; Blanco R; Carmona M; Puig B J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404 [TBL] [Abstract][Full Text] [Related]
14. Melatonin Reduces GSK3β-Mediated Tau Phosphorylation, Enhances Nrf2 Nuclear Translocation and Anti-Inflammation. Das R; Balmik AA; Chinnathambi S ASN Neuro; 2020; 12():1759091420981204. PubMed ID: 33342257 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Sheng JG; Jones RA; Zhou XQ; McGinness JM; Van Eldik LJ; Mrak RE; Griffin WS Neurochem Int; 2001; 39(5-6):341-8. PubMed ID: 11578769 [TBL] [Abstract][Full Text] [Related]
16. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice. Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570 [TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits Aβ-induced microglial inflammatory responses in vitro: Involvement of ERK1/2 and p38 signaling pathways. Shi X; Zheng Z; Li J; Xiao Z; Qi W; Zhang A; Wu Q; Fang Y Neurosci Lett; 2015 May; 594():105-10. PubMed ID: 25818332 [TBL] [Abstract][Full Text] [Related]
18. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide. Kinsner A; Boveri M; Hareng L; Brown GC; Coecke S; Hartung T; Bal-Price A J Neurochem; 2006 Oct; 99(2):596-607. PubMed ID: 16879708 [TBL] [Abstract][Full Text] [Related]
19. HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis. Swaroop S; Sengupta N; Suryawanshi AR; Adlakha YK; Basu A J Neuroinflammation; 2016 Feb; 13():27. PubMed ID: 26838598 [TBL] [Abstract][Full Text] [Related]
20. p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function. Perea JR; Bolós M; Cuadros R; García E; García-Escudero V; Hernández F; McManus RM; Heneka MT; Avila J Mol Neurobiol; 2022 Mar; 59(3):1632-1648. PubMed ID: 35006531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]